PRESS RELEASE published on 11/10/2023 at 07:00, 1 year ago ZÜBLIN IMMOBILIEN HOLDING AG / Publication of Semi-Annual Report 2023/24 as of 30 September 2023
PRESS RELEASE published on 10/03/2023 at 07:00, 1 year 1 month ago Ad hoc announcement pursuant to Article 53 LR ZÜBLIN IMMOBILIEN HOLDING AG / Contract with major tenant extended early
PRESS RELEASE published on 06/23/2023 at 07:00, 1 year 4 months ago Ad hoc announcement pursuant to Art. 53 LR
PRESS RELEASE published on 05/17/2023 at 07:00, 1 year 6 months ago Ad hoc Press Release prusuant to Art. 53 LR / Annual Results 2022-23 and Changes in the Board of Directors
PRESS RELEASE published on 01/22/2023 at 16:01, 1 year 9 months ago Ad hoc announcement pursuant to Article 53 LR ZÜBLIN IMMOBILIEN HOLDING AG / Withdrawal from the board of directors by Vladislav Osipov
Published on 11/21/2024 at 13:30, 35 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 35 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 5 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 5 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 5 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 30 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 50 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 7 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 45 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 20 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 20 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
